Navigation Links
For Super-Obese Patients, Duodenal Switch Beats Gastric Bypass

In the first large, single-institution series directly comparing weight-loss outcomes in super-obese patients, researchers from the University of Chicago found that a newer operation//, the duodenal switch, produced substantially better weight-loss outcomes than the standard operation, the Roux-en-Y gastric bypass.

In the October issue of the Annals of Surgery, the researchers report that the duodenal switch (DS) produced greater weight loss than the Roux-en-Y gastric bypass (RYGB) by all measures in patients with a body mass index (BMI) of at least 50. These patients typically carry at least 150 pounds more than their ideal weight.

In this study, patients undergoing duodenal switch were significantly more likely to achieve and maintain successful weight loss—defined as losing more than half of their excess weight—at one year (DS 83.9% vs. RYGB 70.4%) and three years (DS 84.2% vs. RYGB 59.3%) after surgery.

“While there is no single ideal bariatric procedure that can be applied to all severely obese patients, we have generally recommended the duodenal switch for those with a BMI greater than 50,” said study author Vivek Prachand, M.D., assistant professor of surgery at the University of Chicago. "This study confirms that approach. Both procedures appear to be reasonably safe in the hands of an experienced team, but the duodenal switch appears to offer a considerable advantage in terms of the amount and possibly the duration of weight loss.”

The super obese make up only a fraction of the U.S. obesity pandemic, but their ranks are increasing faster than any other group. When the term was coined in 1987, fewer than one in 2,000 adults in the United States met the criteria of a BMI greater than 50. (A normal BMI is 18.5 to 24.9. From 25 to 29.9 is considered overweight. Thirty or above is considered obese; 40 and above is morbidly obese.) The prevalence of the super-obese has quintupled since then, to one in 400 U.S. adults
'"/>




Page: 1 2 3 4

Related medicine news :

1. Aspirin Benefits Cardiac Disease Patients, Even Before Surgery
2. For High BP Patients, Preventing Enlarged Heart Decreases Risk of Atrial Fibrillation
3. Streamlined Claims a Boon to Patients, Doctors
4. Forcible Detention and Isolation Needed for XDR-TB Patients, warn Experts
5. Statins Aid Survival in Lung Patients, Say Experts
6. The Mental Health Bill Will Not Help Vulnerable Patients, Say Doctors
7. Switching drugs regularly improves HIV treatment
8. Protein acts as "Master Switch" that cuts off cells Cancer-Growth machinery
9. In The Habit Of Taking Painkillers For Your Chronic Headache? Time To Switch Over
10. Unusual Tumor-Suppressor Gene Switches Off in Lung Cancer
11. Switching Off Protein Could Play Key Role In Success Of Radiation Therapy For Cancer
Post Your Comments:
(Date:7/9/2008)... DRE, Inc., a premier international ...ts customers that as much as $250,000 in medical e...e tax filings. , Louisvil...us Act of 2008, in accordance with Tax Code Sectio...equipment bought in 2008. This could make 2008 an ...
(Date:7/9/2008)... While SmartLipo has swept the natio...popular fat removal procedure has leaped forward. ...privileged to be the first in his state to offer t...lard is also one of only two plastic surgeons auth...is procedure. , Lone Tree...
(Date:7/8/2008)...ON, July 8 /PRNewswire-USNewswire/ -- The Justice ...ettlement with the Medical Weight,Loss Clinic, whi...e,Americans with Disabilities Act (ADA). It was al...erve a prospective client because she has HIV,dise...al Weight Loss Clinic will,provide training on the...
(Date:7/8/2008)... SKINTASTIC™ is pleased to a...®--the latest injectable collagen filler in th...uty treatments. EVOLENCE® utilizes highly-puri...red medical grafting substance due to its nearly i... N. Dallas/Plano, TX (PRWEB) July 8...
Breaking Medicine News(10 mins):Health News:Economic Stimulus Act Can Improve Medical Equipment Purchasing Power 2Health News:John A. Millard, M.D. is 1st Surgeon in Colorado to Offer Smartlipo MPX™ 2Health News:John A. Millard, M.D. is 1st Surgeon in Colorado to Offer Smartlipo MPX™ 3Health News:Justice Department Reaches Settlement Agreement With Medical Weight Loss Clinic 2Health News:Move Over, Popular Beauty Fillers--Here Comes Evolence 2Health News:Move Over, Popular Beauty Fillers--Here Comes Evolence 3
...igan, made a new study which showed that an odd ...neck surgery. Ann Arbor say leeches are an effecti...s.Patients who have surgery// to remove cancer in ...d to have tissue transfers performed. Doctors say ...
...researchers have found that the bone marrow cell t...rchers in the US have been studying the ability of...s - to restore function in brain-damaged rats. Ani...s, which came from healthy human volunteers. Comp...
...enes appear to be able to delete sections of DNA, ...nd implications for the evolution of the human gen...A called Line 1 elements jumped around, inserted t...ve effects,// but this is the first time it has be...
...a baby's birth weight is connected to the mother's...lso shows women with the lightest and heaviest off....// More than 4,100 women ages between 62 and 75 y...chers found, as birth weight increased every 2.2 l...
Other Medicine News:Health News:Jumping genes eliminate sections of DNA 2
(Date:7/3/2008)...wire-FirstCall/ -- Medivation, Inc.,(Nasdaq: MDVN...nce at 5:00,p.m. EDT on Monday, July 7, to discuss...d, placebo-controlled Phase 2 clinical trial of,di...e/Webcast Details, To participate in the live cal...telephone, please dial 877-419-6590 from the U.S. ...
(Date:7/3/2008)...RIDGE Massachusetts, July 3,/PRNewswire-FirstCall/...ogy company, Jerini AG for an equity purchase pri... (HAE) product, FIRAZYR(R), to its Human Genetic T...lobal sales expected to be around $350-400 millio... environment, - Expected to be accretive for Non ...
(Date:7/1/2008)...cation Newsletter Series for Healthcare ...July 1 /- Clostridium difficile infec...ase with a wide spectrum of,severity, ranging from...th.,Recurrent CDI can occur in up to 20% of patien...tients are at increased risk of additional,recurre...
(Date:7/1/2008)... for ,buying time, in victims of lethal ...- For the first time, researchers hav...mounts of inhaled or,intravenous hydrogen sulfide,...ir sulfurous stench -- significantly improves surv...gist Mark B. Roth, Ph.D., and colleagues in the Ba...
Breaking Medicine Technology:Medivation to Host Conference Call at 5 p.m. EDT Monday to Discuss Top-Line Phase 2 Study Results in Huntington's Disease 2Shire to add New Orphan Drug to its HGT Portfolio - EU Launch Imminent 2Shire to add New Orphan Drug to its HGT Portfolio - EU Launch Imminent 3Shire to add New Orphan Drug to its HGT Portfolio - EU Launch Imminent 4Shire to add New Orphan Drug to its HGT Portfolio - EU Launch Imminent 5Shire to add New Orphan Drug to its HGT Portfolio - EU Launch Imminent 6Shire to add New Orphan Drug to its HGT Portfolio - EU Launch Imminent 7Shire to add New Orphan Drug to its HGT Portfolio - EU Launch Imminent 8Current Concepts in Clostridium difficile Infection: A Focus on Recurrent Disease 2'Hibernation-On-Demand' Drug Hydrogen Sulfide Significantly Improves Survival After Extreme Blood Loss 2'Hibernation-On-Demand' Drug Hydrogen Sulfide Significantly Improves Survival After Extreme Blood Loss 3CME LLC Granted Five Year Full Approval by the American Psychological Association 4469 1CME LLC Granted Five Year Full Approval by the American Psychological Association 4469 2Immunosyn Corporation to Present at FSX 1465 1Immunosyn Corporation to Present at FSX 1465 2Abbott Named to Science Magazines List of Top Employers in the Biotech and Pharmaceutical Industry 1463 1Abbott Named to Science Magazines List of Top Employers in the Biotech and Pharmaceutical Industry 1463 2Abbott Named to Science Magazines List of Top Employers in the Biotech and Pharmaceutical Industry 1463 3ABCs Private Practice Inaccurately Portrays Serious Womens Health Condition 1461 1ABCs Private Practice Inaccurately Portrays Serious Womens Health Condition 1461 2
...mends clinical utilization management,programs, ST...macy benefit,manager Prime Therapeutics (Prime) to...ation of Strattera(R) (atomoxetine) for treating,a...children. The,study found that children who start ...their therapy than children who started on,stimula...
...eclinical data for potential combination,therapies... after,ITMN-191 exposure, BARCELONA, Spain, April ... announced today the presentation of findings from...tease inhibitor,ITMN-191, alone or in combination ...f the European Association for the Study of the,Li...
Other Medicine Technology:Study Shows Children With ADHD Who Start on Strattera are More,Likely to Change Therapies 2Study Shows Children With ADHD Who Start on Strattera are More,Likely to Change Therapies 3InterMune Presents Research on ITMN-191 in Hepatitis C at EASL,Annual Meeting 2InterMune Presents Research on ITMN-191 in Hepatitis C at EASL,Annual Meeting 3InterMune Presents Research on ITMN-191 in Hepatitis C at EASL,Annual Meeting 4
...UP Laboratories is a national reference laboratory...esearch and development. ARUP offers an extensive ...ts in clinical and anatomic pathology. Owned by th...nclude more than half of the nation's university t...
...UP Laboratories is a national reference laboratory...esearch and development. ARUP offers an extensive ...ts in clinical and anatomic pathology. Owned by th...nclude more than half of the nation's university t...
...UP Laboratories is a national reference laboratory...esearch and development. ARUP offers an extensive ...ts in clinical and anatomic pathology. Owned by th...nclude more than half of the nation's university t...
...UP Laboratories is a national reference laboratory...esearch and development. ARUP offers an extensive ...ts in clinical and anatomic pathology. Owned by th...nclude more than half of the nation's university t...
Medicine Products: